Literature DB >> 7016790

Insulin and renal sodium handling: clinical implications.

R A DeFronzo.   

Abstract

Over the last ten years a large body of information has accumulated which indicates that physiologic changes in the plasma insulin concentration are capable of affecting electrolyte transport by the kidney as well as by variety of other tissues. In the present discussion the effect of insulin on the renal handling of sodium, potassium, phosphate, and calcium is reviewed, with an emphasis on sodium transport (Table 1). An attempt is made to relate the effects of insulin on sodium metabolism to four common clinical situations: (a) hypertension and obesity, (b) sodium wasting in diabetes mellitus, (c) natriuresis of starvation, and (d) sodium retention and edema following refeeding.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016790

Source DB:  PubMed          Journal:  Int J Obes


  17 in total

Review 1.  Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Xuan Li; Zhen Wang; Alan J Mouton; John E Hall
Journal:  Can J Cardiol       Date:  2020-02-12       Impact factor: 5.223

2.  Urinary sodium excretion: association with hyperinsulinaemia, hypertension and sympathetic nervous system activity in obese and control children.

Authors:  G Csábi; D Molnár; G Hartmann
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

3.  Contribution of change in glycosylated haemoglobin to insulin-associated weight gain: results of a longitudinal study in type 2 diabetic patients.

Authors:  H J Jansen; J C Hendriks; B E de Galan; G Penders; C J Tack; G Vervoort
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

4.  Alcohol and obesity: a new look at high blood pressure and stroke. An epidemiological study in preventive neurology.

Authors:  H H Kornhuber; G Lisson; L Suschka-Sauermann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 5.  Adverse metabolic effects of antihypertensive drugs. Implications for treatment.

Authors:  H G Preuss; J F Burris
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

6.  Perirenal Fat and Association With Metabolic Risk Factors: The Uberlândia Heart Study.

Authors:  Leonardo Roever; Elmiro S Resende; Fernando C Veloso; Angélica L D Diniz; Nilson Penha-Silva; Antonio Casella-Filho; Paulo M M Dourado; Antonio C P Chagas
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.889

Review 7.  The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.

Authors:  Massimo Leggio; Mario Lombardi; Elisa Caldarone; Paolo Severi; Stefania D'Emidio; Massimo Armeni; Veronica Bravi; Maria Grazia Bendini; Andrea Mazza
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

Review 8.  Race and hypertension. What is clinically relevant?

Authors:  D R Rutledge
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

Review 9.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

Review 10.  Preventing and managing cardiometabolic risk: the logic for intervention.

Authors:  Mark A Pereira; Thomas E Kottke; Courtney Jordan; Patrick J O'Connor; Nicolaas P Pronk; Rita Carreón
Journal:  Int J Environ Res Public Health       Date:  2009-09-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.